Zilucoplan (RA101495) ( DrugBank: Zilucoplan )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
11	重症筋無力症	2
62	発作性夜間ヘモグロビン尿症	1

11. 重症筋無力症

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05514873 (ClinicalTrials.gov)	October 31, 2022	22/8/2022	An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in ...	A Phase 3b, Multicenter, Open-Label, Single-Arm Study to Evaluate the Safety, Tolerability, and Effi ...	Generalized Myasthenia Gravis	Drug: zilucoplan (RA101495)	UCB Biopharma SRL	NULL	Recruiting	18 Years	85 Years	All	20	Phase 3	United States
2	NCT04225871 (ClinicalTrials.gov)	December 23, 2019	2/10/2019	Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis	A Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects With Generalized Myasth ...	Generalized Myasthenia Gravis	Drug: zilucoplan (RA101495)	Ra Pharmaceuticals, Inc.	NULL	Active, not recruiting	18 Years	N/A	All	200	Phase 3	United States;Canada;France;Germany;Italy;Japan;Norway;Poland;Spain;United Kingdom

臨床試験数 : 292 / 薬物数 : 151 - (DrugBank : 49) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 108

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03225287 (ClinicalTrials.gov)	July 17, 2017	17/7/2017	Extension Study of RA101495 for Patients With PNH Who Have Completed a Zilucoplan (RA101495)Clinical ...	A Multicenter, Open-label, Uncontrolled, Extension Study of RA101495 in Subjects With Paroxysmal Noc ...	Paroxysmal Nocturnal Hemoglobinuria (PNH)	Drug: Zilucoplan (RA101495)	Ra Pharmaceuticals, Inc.	NULL	Terminated	18 Years	N/A	All	19	Phase 2	United States;Australia;Canada;Finland;Germany;Hungary;New Zealand;United Kingdom;Denmark